Immunic Appoints Jaa Roberson as Chief People Officer
Immunic appointed Jaa Roberson as Chief People Officer, a newly created executive role, effective immediately. Roberson brings two decades of biopharma HR experience, most recently scaling Day One Biopharmaceuticals from 37 to 200 employees through its clinical-to-commercial transition. She will report directly to CEO Erik Lundgren and help build the organization ahead of potential commercialization. The hire signals Immunic's preparation for the pivotal Phase 3 ENSURE read-out of vidofludimus calcium in relapsing MS, expected by the end of 2026, and a potential shift to a fully integrated commercial company.
Key figures
- Option vesting
- 25% on one-year anniversary of Oct 19, 2026, remainder in 36 equal monthly installments
- Inducement options
- 190000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.